Aesku Diagnostics

Executive Summary

Aesku Diagnostics (Aesku.Group) is a German biotechnology company specializing in autoimmune diagnostics, offering a comprehensive portfolio of IFA, ELISA, and blot tests along with laboratory automation and software. Founded in 2003 and headquartered in Wendelsheim, the company has established a global presence and focuses on translating scientific research into practical diagnostic solutions. With a mission to improve patient outcomes in autoimmunity, Aesku combines innovative product development with integrated automation systems to enhance lab efficiency and diagnostic accuracy. As a private company, Aesku continues to invest in expanding its product line and geographic reach, positioning itself as a key player in the autoimmune diagnostics market. The company's growth is underpinned by increasing global awareness of autoimmune diseases and demand for precise, automated diagnostic tools.

Upcoming Catalysts (preview)

• Q4 2026Launch of Next-Generation Automated ELISA Platform75% success
• Q1 2027Expansion into U.S. Market via FDA 510(k) Clearances60% success
• Q3 2026Partnership with Major Diagnostic Distributor in Asia-Pacific70% success